Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 25Gastrointestinal 4Plasma cell 3Thoracic 2Other 2Myeloid 2Genitourinary 2Breast 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 550Head and Neck Neoplasms 490Carcinoma, Non-Small-Cell Lung 338Melanoma 217Colorectal Neoplasms 206Ovarian Neoplasms 174Neoplasms 171Breast Neoplasms 168Stomach Neoplasms 141Carcinoma, Renal Cell 133Uterine Cervical Neoplasms 129Neoplasm Metastasis 129Triple Negative Breast Neoplasms 125Lung Neoplasms 118Pancreatic Neoplasms 117Esophageal Neoplasms 107Thyroid Neoplasms 95Endometrial Neoplasms 93Urinary Bladder Neoplasms 92Prostatic Neoplasms 88Sarcoma 81Carcinoma, Squamous Cell 81Carcinoma, Transitional Cell 75Small Cell Lung Carcinoma 74Carcinoma, Hepatocellular 65Recurrence 53Nasopharyngeal Carcinoma 52Carcinoma 47Colonic Neoplasms 46Cholangiocarcinoma 43

Interventions

Gemcitabine 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Venous Thromboembolism × Head & Neck × Clear all
NCT01325558 2016-07-15

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Altor BioScience

Phase 1 Completed
30 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡